|
Art. 104abis Placing information about the authorised representative 141
For class I devices and for systems and procedure packs that are placed on the market in accordance with the new legislation, the information specified in Annex 1 Chapter III Section 23.2 letter d EU-MDR142 about the authorised representative in accordance with Article 51 paragraph 1 or 5 of this Ordinance may be included in a document accompanying the device until 31 July 2023. 141 Inserted by Annex 5 No 1 of the O of 4 May 2022 on In Vitro Diagnostic Medical Devices, in force since 26 May 2022 (AS 2022 291). 142 See the footnote to Art. 4 para. 1 let. f. |